These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 38752901)
1. Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus. Santos-Pardo I; Andersson Franko M; Lagerqvist B; Ritsinger V; Eliasson B; Witt N; Norhammar A; Nyström T J Am Coll Cardiol; 2024 Jul; 84(3):260-272. PubMed ID: 38752901 [TBL] [Abstract][Full Text] [Related]
2. Visit-to-visit HbA Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588 [TBL] [Abstract][Full Text] [Related]
3. Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter? Baber U J Am Coll Cardiol; 2024 Jul; 84(3):273-275. PubMed ID: 38986669 [No Abstract] [Full Text] [Related]
4. A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus: The RESERVOIR Clinical Trial. Romaguera R; Gómez-Hospital JA; Gomez-Lara J; Brugaletta S; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Montanya E; Fernandez-Ortiz A; Alfonso F; Valgimigli M; Sabate M; Cequier A JACC Cardiovasc Interv; 2016 Jan; 9(1):42-50. PubMed ID: 26762910 [TBL] [Abstract][Full Text] [Related]
5. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials. Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627 [TBL] [Abstract][Full Text] [Related]
6. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus. Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177 [TBL] [Abstract][Full Text] [Related]
7. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes. Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048 [TBL] [Abstract][Full Text] [Related]
8. Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study). Schoos MM; Dangas GD; Mehran R; Kirtane AJ; Yu J; Litherland C; Clemmensen P; Stuckey TD; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Maehara A; Stone GW Am J Cardiol; 2016 Jan; 117(2):192-200. PubMed ID: 26639039 [TBL] [Abstract][Full Text] [Related]
9. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study. Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like-peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes in diabetes in relation to achieved glycemic control. A Danish nationwide study. Zareini B; Sørensen KK; Pedersen-Bjergaard U; Loldrup Fosbøl E; Køber L; Torp-Pedersen C J Diabetes; 2024 Jun; 16(6):e13560. PubMed ID: 38751369 [TBL] [Abstract][Full Text] [Related]
11. Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR). Buccheri S; James S; Lindholm D; Fröbert O; Olivecrona GK; Persson J; Hambraeus K; Witt N; Erlinge D; Angerås O; Lagerqvist B; Sarno G Eur Heart J; 2019 Aug; 40(31):2607-2615. PubMed ID: 31079155 [TBL] [Abstract][Full Text] [Related]
12. Proximal coronary artery intervention: stent thrombosis, restenosis and death. Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859 [TBL] [Abstract][Full Text] [Related]
14. New-onset diabetes in elderly subjects: association between HbA1c levels, mortality, and coronary revascularization. Twito O; Ahron E; Jaffe A; Afek S; Cohen E; Granek-Catarivas M; Klein P; Hermoni D Diabetes Care; 2013 Nov; 36(11):3425-9. PubMed ID: 23877985 [TBL] [Abstract][Full Text] [Related]
15. Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence. Bajraktari G; Jashari H; Ibrahimi P; Alfonso F; Jashari F; Ndrepepa G; Elezi S; Henein MY Int J Cardiol; 2016 Sep; 218():126-135. PubMed ID: 27232924 [TBL] [Abstract][Full Text] [Related]
16. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301 [TBL] [Abstract][Full Text] [Related]
17. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry. Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis: The RIBS VI Study. Cuesta J; Pérez-Vizcayno MJ; García Del Blanco B; Bosa F; Pérez de Prado A; Rumoroso JR; Romaguera R; Gutiérrez H; García Touchard A; López-Mínguez JR; Trillo R; de la Torre Hernández JM; Moreno R; Velázquez M; Moris C; Kockar MJ; Jiménez-Quevedo P; Bastante T; Del Val D; Rivero F; Alfonso F JACC Cardiovasc Interv; 2024 Aug; 17(15):1825-1836. PubMed ID: 39142758 [TBL] [Abstract][Full Text] [Related]
19. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan. Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559 [TBL] [Abstract][Full Text] [Related]
20. Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis. Habara S; Kadota K; Kuwayama A; Shimada T; Ohya M; Miura K; Amano H; Kubo S; Hyodo Y; Otsuru S; Tada T; Tanaka H; Fuku Y; Goto T Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27932532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]